Purpose. The literature was reviewed to determine whether data support current treatment guideline recommendations regarding the use of systemic corticosteroids in the treatment of chronic ...

Retrospective study of an uncommon disease in a non-tuberculosis endemic country with focus on treatment modalities and ...

Then there’s physical activity: Many of the symptoms of lupus, such as joint pain, fatigue, and depression, may make patients ...

It is written: both systemic and topical corticosteroids can exacerbate or precipitate acne or even induce an acneform eruption. Corticosteroids are considered to be acnegenic comedogenic drugs ...

Discover how targeting E3-X ligase could revolutionize SLE treatment by enhancing anti-inflammatory effects while reducing ...

WASHINGTON -- Patients with IgG4-related disease appeared to benefit from inebilizumab (Uplizna), currently approved for ...

InflaRx shares rose 12% in premarket trading after regulators issued a positive opinion recommending marketing authorization of Gohibic. Shares on Friday were trading around $2.27. The stock is up 25% ...

InflaRx (IFRX) announced that the Committee for Medicinal Products for Human Use of the European Medicines Agency has adopted a positive ...

KEY POINTS A 72-year-old man presented to the emergency department with a 2-week history of hypotension, postural dizziness, and muscle weakness. He had a medical history of HIV, lipodystrophy, ...

Palatin Announces Completion of Patient Enrollment in Phase 2 Study of Orally Administered Melanocortin Agonist PL8177 in Ulcerative Colitis ...

William Blair analyst Sami Corwin has maintained their bullish stance on CABA stock, giving a Buy rating on November 15.Don't Miss our Black ...